Biblio
Export 1218 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is W [Clear All Filters]
“Daily Physical Activity Patterns During the Early Stage of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 659-667, 2017.
, “Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1411-1427, 2017.
, “Detecting At-Risk Alzheimer's Disease Cases.”, J Alzheimers Dis, vol. 60, no. 1, pp. 97-105, 2017.
, “Diabetes and Alzheimer's Disease: Can Tea Phytochemicals Play a Role in Prevention?”, J Alzheimers Dis, vol. 59, no. 2, pp. 481-501, 2017.
, “The Diagnostic and Prognostic Value of Neuropsychological Assessment in Memory Clinic Patients.”, J Alzheimers Dis, vol. 55, no. 2, pp. 679-689, 2017.
, “Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.”, J Alzheimers Dis, vol. 58, no. 2, pp. 355-359, 2017.
, “Diaschisis-Like Association of Hippocampal Atrophy and Posterior Cingulate Cortex Hypometabolism in Cognitively Normal Elderly Depends on Impaired Integrity of Parahippocampal Cingulum Fibers.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1285-1294, 2017.
, “Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation.”, J Alzheimers Dis, vol. 57, no. 2, pp. 475-482, 2017.
, “Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 981-993, 2017.
, “Does Functional Connectivity Provide a Marker for Cognitive Rehabilitation Effects in Alzheimer's Disease? An Interventional Study.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1303-1313, 2017.
, “Early Evidence of Low Bone Density and Decreased Serotonergic Synthesis in the Dorsal Raphe of a Tauopathy Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1605-1619, 2017.
, “Effect of APOE Genotype on Amyloid Deposition, Brain Volume, and Memory in Cognitively Normal Older Individuals.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1293-1302, 2017.
, “Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1129-1135, 2017.
, “Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-β Concentration.”, J Alzheimers Dis, vol. 56, no. 3, pp. 885-891, 2017.
, “Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1131-1139, 2017.
, “Effect Size Analyses of Souvenaid in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1131-1139, 2017.
, “The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1255-1267, 2017.
, “The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1255-1267, 2017.
, “Effects of DHA Supplementation on Hippocampal Volume and Cognitive Function in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized, Double-Blind, Placebo-Controlled Trial.”, J Alzheimers Dis, vol. 55, no. 2, pp. 497-507, 2017.
, “The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 327-334, 2017.
, “The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 327-334, 2017.
, “The Effects of LW-AFC on the Hippocampal Transcriptome in Senescence-Accelerated Mouse Prone 8 Strain, a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 227-240, 2017.
, “Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1325-1334, 2017.
, “Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 57, no. 2, pp. 387-393, 2017.
, “Efficacy and Safety of Donepezil in Chinese Patients with Severe Alzheimer's Disease: A Randomized Controlled Trial.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1495-1504, 2017.
,